Reference number : 236-2018-2019-Q1-00822, amendment number : 1, agreement type : G, recipient legal name : Chandhoke, Amrita Singh, recipient country : US, recipient province : nan, recipient city : Boston, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 50000.0, agreement start date : 2018-05-01, agreement end date : 2019-03-30, description english : Targeting acquired resistance to oncogenic KRAS inhibition in Pancreatic cancer models using quantitative chemoproteomics, description french : Targeting acquired resistance to oncogenic KRAS inhibition in Pancreatic cancer models using quantitative chemoproteomics, expected results english : nan, expected results french : nan, additional information english : Amendment 1: Agreement Value in CAD and Projected Agreement End Date., additional information french : Modifications 1: Valeur de l'entente en dollars canadiens et la date de fin prévue de l'entente., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada